Misleading Surrogate Evidence for FDA’s Aduhelm Approval
Amsterdam, November 16, 2022 – Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by ...
Amsterdam, November 16, 2022 – Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by ...
Early approval pathways for drugs – intended to strike a compromise between access to promising therapies today, and confirmatory evidence ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.